Co-occurrence of dual carbapenemases KPC-2 and OXA-48 with the mobile colistin resistance gene

Aminoglycosides Anti-Bacterial Agents / pharmacology Bacterial Proteins Colistin / pharmacology Drug Resistance, Bacterial / genetics Enterobacter / genetics Microbial Sensitivity Tests Plasmids / genetics beta-Lactamases / genetics
Enterobacter MCR-9.1 dual carbapenemases KPC-2 and OXA-48 extreme-drug resistance mobile colistin resistance plasmid xangfangensis

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2022
Historique:
received: 03 06 2022
accepted: 25 07 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

Bacterial infections with the genus

Identifiants

DOI: 10.3389/fcimb.2022.960892 PMID: 36061873 PMC: PMC9428693
pubmed: 36061873
doi: 10.3389/fcimb.2022.960892
pmc: PMC9428693
doi:

Substances chimiques

Aminoglycosides 0
Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6
Colistin Z67X93HJG1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

960892

Informations de copyright

Copyright © 2022 Yao, Doijad, Falgenhauer, Schmiedel, Imirzalioglu and Chakraborty.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Microbiol Spectr. 2021 Sep 3;9(1):e0066121
pubmed: 34378957
Infect Drug Resist. 2020 Jan 10;13:129-137
pubmed: 32021327
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1135-1140
pubmed: 28096418
Microb Genom. 2021 Nov;7(11):
pubmed: 34739369
Clin Infect Dis. 2001 Feb 15;32(4):e69-77
pubmed: 11181139
PLoS Pathog. 2019 Jun 6;15(6):e1007726
pubmed: 31170271
ISME J. 2017 Mar;11(3):651-662
pubmed: 27959344
Clin Infect Dis. 2004 Sep 15;39(6):812-8
pubmed: 15472813
Syst Appl Microbiol. 2021 Jan;44(1):126174
pubmed: 33370657
Emerg Infect Dis. 2018 Jun;24(6):1010-1019
pubmed: 29774858
mSystems. 2020 Aug 4;5(4):
pubmed: 32753511
Microbiol Rev. 1983 Sep;47(3):361-409
pubmed: 6355806
ISME J. 2021 Jul;15(7):1879-1892
pubmed: 33824426
BMC Genomics. 2022 Jan 8;23(1):20
pubmed: 34996351
Genome Announc. 2014 Nov 13;2(6):
pubmed: 25395635
Emerg Infect Dis. 2021 Jan;27(1):161-169
pubmed: 33350909
mSphere. 2020 Aug 5;5(4):
pubmed: 32759337
Front Cell Infect Microbiol. 2021 Nov 11;11:744431
pubmed: 34858870
Front Cell Infect Microbiol. 2019 Jan 04;8:446
pubmed: 30662878
J Glob Antimicrob Resist. 2020 Mar;20:285-289
pubmed: 31494305
Sci Rep. 2020 May 15;10(1):8113
pubmed: 32415232
FEMS Microbiol Lett. 2012 Mar;328(1):46-53
pubmed: 22150997
Microbiology (Reading). 2009 May;155(Pt 5):1478-1488
pubmed: 19372158
J Antimicrob Chemother. 2020 Sep 1;75(9):2452-2461
pubmed: 32514538
Drug Resist Updat. 2016 Nov;29:30-46
pubmed: 27912842
Microb Drug Resist. 2018 Nov;24(9):1305-1315
pubmed: 29750595
Front Med (Lausanne). 2018 Jun 13;5:181
pubmed: 29951482
mBio. 2019 May 7;10(3):
pubmed: 31064835
mBio. 2021 Jan 26;12(1):
pubmed: 33500343
Antimicrob Agents Chemother. 2020 Jul 22;64(8):
pubmed: 32513803
Antimicrob Agents Chemother. 2019 May 24;63(6):
pubmed: 30962338
Clin Microbiol Rev. 1997 Apr;10(2):220-41
pubmed: 9105752
J Antimicrob Chemother. 2016 Nov;71(11):3058-3061
pubmed: 27494907
Front Microbiol. 2018 Aug 14;9:1885
pubmed: 30154783
BMC Bioinformatics. 2013 Feb 21;14:60
pubmed: 23432962
Genome Biol. 2014;15(11):524
pubmed: 25410596
Clin Microbiol Infect. 2021 Dec;27(12):1856.e7-1856.e13
pubmed: 33915285
F1000Res. 2018 May 1;7:521
pubmed: 30430006
Sci Rep. 2018 Mar 29;8(1):5392
pubmed: 29599516
Mol Microbiol. 2019 Jun;111(6):1604-1616
pubmed: 30873646
mSphere. 2019 Sep 11;4(5):
pubmed: 31511372
Clin Microbiol Rev. 2019 Jul 17;32(4):
pubmed: 31315895
BMC Genomics. 2011 Aug 08;12:402
pubmed: 21824423
Microb Pathog. 2010 Sep;49(3):83-9
pubmed: 20451600
Antimicrob Agents Chemother. 2019 Aug 23;63(9):
pubmed: 31209009
Nucleic Acids Res. 2016 Jan 4;44(D1):D694-7
pubmed: 26578559
Int J Syst Evol Microbiol. 2018 Jan;68(1):461-466
pubmed: 29292687
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19126-31
pubmed: 19855009
Int J Antimicrob Agents. 2016 Dec;48(6):764-765
pubmed: 27742202
J Antimicrob Chemother. 2018 Apr 1;73(4):883-890
pubmed: 29373760
Front Microbiol. 2018 Apr 04;9:658
pubmed: 29670607
Antimicrob Resist Infect Control. 2018 May 2;7:62
pubmed: 29744043
Antimicrob Agents Chemother. 2015 Mar;59(3):1824-5
pubmed: 25547359
Sci Rep. 2021 Jan 22;11(1):2136
pubmed: 33483623
mBio. 2016 Dec 13;7(6):
pubmed: 27965456

Auteurs

Yancheng Yao (Y)

Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus-Liebig University Giessen, Giessen, Germany.

Swapnil Doijad (S)

Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus-Liebig University Giessen, Giessen, Germany.

Jane Falgenhauer (J)

Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus-Liebig University Giessen, Giessen, Germany.

Judith Schmiedel (J)

Institute of Medical Microbiology, University Hospital Giessen, Giessen, Germany.

Can Imirzalioglu (C)

Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus-Liebig University Giessen, Giessen, Germany.
Institute of Medical Microbiology, University Hospital Giessen, Giessen, Germany.

Trinad Chakraborty (T)

Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus-Liebig University Giessen, Giessen, Germany.
Institute of Medical Microbiology, University Hospital Giessen, Giessen, Germany.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Atomic view of photosynthetic metabolite permeability pathways and confinement in synthetic carboxysome shells.

Daipayan Sarkar, Christopher Maffeo, Markus Sutter et al.
1.00
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH

questionsmedicales.fr › Glucides › Hétérosides › Aminosides › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Perforines › Peptides antimicrobiens cationiques › Polymyxines › Colistine › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Enterobacter › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › Co-occurrence of dual carbapenemases KPC-2 and...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Co-occurrence of dual carbapenemases KPC-2 and...